Ligand (LGND) Breakout! Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Ligand (LGND) Breakout!

LGND 188.97

-0.6%

Dec 31 3:59 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: John O'Neill who wrote (18938)	4/14/1998 5:19:00 PM
From: Andreas Helke	Read Replies (1) of 32384

The better question is what can prevent Ligand from reaching $25? I think the only realistic scenario for that is that a miracle cure against cancer makes Ligands cancer medications obsolete and at the same time the non cancer parts of Ligands pipeline does not have much success. The usual stumbling blocks for biotech companies like disappointing trial results, unexpected side effects or missed FDA approvals could delay the move to $25 but with Ligands excellent pipeline and financial position there is no danger that the company disappears into obscurity. On the chance for approval front both Panretin and Targretin look very good. I have no doubt that the Panretin gel will be approved. Ligand shares seem to know only two conditions. Seriously undervalued is alternating with a even more undervalued state. Im curious if Ligand shares will ever be overvalued. Another good question with a less clear answer is wether Ligand will reach $25 early enough to make it a good investment for current shareholders? Andreas

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next